|
Market Cap (1-Jul) $50,607,588 (781st) |
Close (30-Jun) $0.250 |
Volume (30-Jun) 84,565 |
Shortsold (19-Jun) 845,024 (0.14%) (403rd) |
|
52w High $0.59 |
52w Low $0.075 |
P/E 8.00 |
EPS -0.01 |
MDR released this announcement to the ASX on 21 December 2022, 8:21. The announcement is marked as price sensitive, and is 2 page(s) in length and 78.71kb in size.
You can view all announcements from MDR and see how they appear on a price chart on the announcements page.
At the date of this announcement, MDR was 0.012% short sold according to ASIC data. It was ranked the 596th most shorted stock on the ASX. It is now ranked as the 403rd most shorted stock on the ASX with 0.135% of total shares short sold as of the latest reported data (19 June 2025).
| Other Recent Announcements from MDR | |
|---|---|
| MDR undertakes strategic review | 22 June 2023, 9:51 |
| Initial Director's Interest Notice - Kate Hill | 29 May 2023, 11:05 |
| Initial Director's Interest Notice - Brett Magun | 29 May 2023, 11:00 |
| MDR expects 1H FY23 revenue to be up 50-60% on 1H FY22 | 21 December 2022, 8:21 |
| Change in substantial holding | 15 December 2022, 17:04 |
| Change of Director's Interest Notice - Xenos | 30 November 2022, 17:20 |
| Change of Director's Interest Notice - Merrow | 30 November 2022, 17:13 |
You must be logged in to post a reply.
MedAdvisor 